This content was recorded from the live internet event on August 19th and 20th, 2020. If you attended and claimed credit, please do not complete this release. 

Faculty

Needs Statement

There is a tendency to over focus on single drug use and problems, e.g., “opioids” and “opioid overdose”. There is a need to focus more on polysubstance use and problems.

Target Audience

This activity is designed for physicians, nurse practitioners, nurses, physician assistants, first responders, public health professionals and students, and other interested healthcare or public health professionals.

Objectives

Upon completion of this educational activity, participants will be able to:

• Describe the epidemiology and time trends in drug overdose mortality in the US
• State 2 possible reasons for the rise in stimulant deaths
• Discuss the qualitative perspectives on opioid and stimulant co-use 

Accreditation

In support of improving patient care, this activity has been planned and implemented by University of Kentucky HealthCare CECentral and the Kentucky Department of Public Health. University of Kentucky HealthCare CECentral is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

AMA credit: 
This enduring material is designated for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

ANCC credit:
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.00 nursing contact hour(s).

Other credit:
UK Healthcare CECentral certifies this activity for 1.00 hours of participation.

Faculty Disclosure

Dr. Dan Ciccarone has the following relevant fincancial interests to disclose:

• Celero Systems – Scientific Advisory Board
• Arbor Pharmaceuticals – advisor

No other speakers, planners or content reviewers have any relevant financial relationships to disclose.

The material presented in this course represents information obtained from the scientific literature as well as the clinical experiences of the speakers. In some cases, the presentations might include discussion of investigational agents and/or off-label indications for various agents used in clinical practice. Speakers will inform the audience when they are discussing investigational and/or off-label uses.

Content review confirmed that the content was developed in a fair, balanced manner free from commercial bias. Disclosure of a relationship is not intended to suggest or condone commercial bias in any presentation, but it is made to provide participants with information that might be of potential importance to their evaluation of a presentation.

Acknowledgment

This activity is jointly provided by the University of Kentucky and Kentucky Department of Public Health.

In collaboration with the Lake Cumberland District Health Department (LKDHD), Kentucky Injury Prevention and Research Center University of Kentucky College of Public Health (KIPRC), Kentucky Department for Public Health (KDPH), Kentucky Income Reinvestment Program (KIRP), Kentucky AIDS Education Training Center (KYAETC), and the Department for Behavioral Health, Developmental and Intellectual Disabilities (DBHDID)